XMax Inc. has signed a five-year agreement to access high-performance AI computing infrastructure in Korea via kt cloud, aiming to support its NeoCloud and AI Token Factory platforms. This infrastructure includes 512 NVIDIA GPUs and 560TB storage, enabling advanced AI inference services. XMax plans to commercialize AI products for finance, government, and industry sectors, projecting over $100 million in revenue over five years. The company is currently completing technical validation and preparing for platform launch.
XMax's AI infrastructure services agreement is the subject, with Pluang's market data providing context. For readers following the Technology sector, 96 of 150 US stocks rose while 40 fell as of Nov 02, 2026 19:21 WIB. Notable movers include Applovin Corporation at USD 236.12 (+3.34%), Nokia Corp at USD 8.80 (+3.17%), and STMicroelectronics NV at USD 48.15 (+3.02%).
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
